These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
405 related articles for article (PubMed ID: 16961952)
1. Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease. Twamley EW; Ropacki SA; Bondi MW J Int Neuropsychol Soc; 2006 Sep; 12(5):707-35. PubMed ID: 16961952 [TBL] [Abstract][Full Text] [Related]
2. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets. Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL; Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169 [TBL] [Abstract][Full Text] [Related]
3. The Neuropsychological Correlates of Brain Perfusion and Gray Matter Volume in Alzheimer's Disease. Tai H; Hirano S; Sakurai T; Nakano Y; Ishikawa A; Kojima K; Li H; Shimada H; Kashiwado K; Mukai H; Horikoshi T; Sugiyama A; Uno T; Kuwabara S J Alzheimers Dis; 2020; 78(4):1639-1652. PubMed ID: 33185599 [TBL] [Abstract][Full Text] [Related]
4. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set. Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489 [TBL] [Abstract][Full Text] [Related]
5. Mapping progressive brain structural changes in early Alzheimer's disease and mild cognitive impairment. Apostolova LG; Thompson PM Neuropsychologia; 2008; 46(6):1597-612. PubMed ID: 18395760 [TBL] [Abstract][Full Text] [Related]
6. [Neuropsychological correlates of cerebral atrophy in Alzheimer's dementia]. Pantel J; Schönknecht P; Essig M; Schröder J Fortschr Neurol Psychiatr; 2004 Apr; 72(4):192-203. PubMed ID: 15095176 [TBL] [Abstract][Full Text] [Related]
7. In vivo detection of microstructural correlates of brain pathology in preclinical and early Alzheimer Disease with magnetic resonance imaging. Zhao Y; Raichle ME; Wen J; Benzinger TL; Fagan AM; Hassenstab J; Vlassenko AG; Luo J; Cairns NJ; Christensen JJ; Morris JC; Yablonskiy DA Neuroimage; 2017 Mar; 148():296-304. PubMed ID: 27989773 [TBL] [Abstract][Full Text] [Related]
8. Cognitive phenotypes, brain morphometry and the detection of cognitive decline in preclinical AD. Jacobson MW; McEvoy LK; Dale A; Fennema-Notestine C Behav Neurol; 2009; 21(1):29-37. PubMed ID: 19847043 [TBL] [Abstract][Full Text] [Related]
9. Differential neuropsychological patterns of frontal variant frontotemporal dementia and Alzheimer's disease in a study of diagnostic concordance. Giovagnoli AR; Erbetta A; Reati F; Bugiani O Neuropsychologia; 2008 Apr; 46(5):1495-504. PubMed ID: 18262206 [TBL] [Abstract][Full Text] [Related]
19. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e. Susanto TA; Pua EP; Zhou J; J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955 [TBL] [Abstract][Full Text] [Related]
20. Imaging is superior to cognitive testing for early diagnosis of Alzheimer's disease. Zamrini E; De Santi S; Tolar M Neurobiol Aging; 2004; 25(5):685-91. PubMed ID: 15172748 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]